Test Price
4,600 AED✅ Home Collection Available
Oncomine Juvenile Myelomonocytic Leukemia (JMML) Panel in UAE | 4600 AED | DHA Approved Molecular Diagnostics
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Specimen Collection: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Oncomine JMML Panel is an advanced next-generation sequencing (NGS) assay that analyzes 42 genes critical for diagnosing juvenile myelomonocytic leukemia, providing a comprehensive molecular profile for pediatric patients. This assay detects single nucleotide variants, insertions/deletions, and copy number alterations in genes such as PTPN11, NRAS, KRAS, NF1, CBL, and others, enabling precise risk stratification and targeted therapy decisions.
| Feature | Oncomine JMML Panel (Our Test) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) – 42 genes | Sanger sequencing – 1 gene |
| Turnaround Time | Batch processing: sample by 1st/16th, report 15th/30th same month | ~7–14 days (variable) |
| Diagnostic Sensitivity | 99.9% | ~95% |
| Clinical Utility | Full mutational landscape for prognosis & targeted therapy | Limited to known mutation; low prognostic power |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I emphasize that the Oncomine JMML Panel provides an unparalleled molecular map for juvenile myelomonocytic leukemia. However, results must always be correlated with clinical presentation, bone marrow morphology, and peripheral blood counts. This panel is a powerful tool, not a standalone diagnosis.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Clinical Advisory
Do not discontinue or alter any prescribed medication based solely on genetic test results. All treatment decisions must be made by the treating physician in conjunction with clinical and laboratory data.
Patients presenting with fever >38.5°C, active bleeding, severe bruising, suspected tumor lysis syndrome, or acute neurological changes should seek emergency medical care immediately.
Exclusion Criteria for Sample Acceptance
- Frozen or clotted specimens – sample must be shipped refrigerated, never frozen.
- Missing mandatory NGS Test Requisition Form (Form 40).
- Recent blood transfusion within 2 weeks may alter variant allele frequencies.
- Sample volume less than 2 mL (minimum).
Patient FAQ & Clinical Guidance
1. What is the clinical utility of the Oncomine JMML Panel?
The panel sequences 42 genes to confirm a diagnosis of juvenile myelomonocytic leukemia, identify actionable mutations, and guide risk stratification. This information helps clinicians decide between watchful waiting, chemotherapy, or hematopoietic stem cell transplantation.
2. How should the sample be collected and transported?
The sample must be collected in a hospital setting only. For bone marrow aspirate or peripheral blood, collect 3 mL in EDTA. Immediately refrigerate (2–8°C) and ship with the completed NGS Test Requisition Form (Form 40). Do not freeze. Our medical courier will retrieve the specimen under strict cold-chain conditions.
3. Is this test covered by UAE insurance plans?
Direct insurance billing verification via WhatsApp +971 54 548 8731 confirms your coverage instantly. Our team assists with pre-authorization documentation and direct handling with major UAE insurers.
UAE Regulatory & Data Privacy Adherence
Legal & Accreditation Compliance
All genetic testing and patient data handling comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed under Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory holds ISO 9001:2015 Certification (Cert: INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143.
Contact: +971 54 548 8731 | Service hours: 8 AM – 11 PM daily.
Clinical & Logistical Metadata
| Test Name | Oncomine Juvenile Myelomonocytic Leukemia (JMML) Panel |
| Price (AED) | 4,600 |
| Turnaround Time | Batch processing: sample by 1st/16th, report 15th/30th same month |
| Sample Type / Matrix | Bone marrow aspirate or peripheral whole blood (EDTA) – hospital extraction only |
| Methodology Used | Next-Generation Sequencing (Ion Torrent / Oncomine Comprehensive Assay) – 42 genes |
| ICD-10-CM Code | C93.3 (Juvenile myelomonocytic leukemia) |
| LOINC Code | 96972-0 (NGS panel for hematologic malignancy) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians